Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue

Abstract Objective. Aberrant expression of immunoglobulin (Ig) by cancer cells has been documented in a number of malignant tumors but its biological significance is unclear. Cancer cells overexpress anti-apoptotic molecules such as Bcl-xL. The present study aimed to examine the role of expression of Ig light-chain Igĸ and Igλ in maintaining the high levels of Bcl-xL in colorectal cancer cells. Material and methods. Thirty patients with colorectal cancer were recruited to this study. Expression of Igĸ, Igλ and Bcl-xL in surgically removed cancer tissue was examined by immunohistochemistry and/or flow cytometry. Using the HT29 cell line as a study platform, RNA interference (RNAi) was employed to knock out the genes of Igĸ and Igλ in the cancer cell line; the expression of Bcl-xL in HT29 cells was subsequently analyzed. Results. Human colorectal cancer cells, but not normal colorectal tissue, expressed both Igĸ and Igλ in the cytoplasm. High levels of Bcl-xL were detected in cancer cells. Using RNAi to knock out the genes of Igĸ and/or Igλ, Bcl-xL expression in HT29 cells was significantly suppressed and the cells became apoptotic. Conclusion. The results suggest that expression of Igĸ and Igλ is required to stabilize Bcl-xL expression in cancer cells.

[1]  Ahmedin Jemal,et al.  International Trends in Colorectal Cancer Incidence Rates , 2009, Cancer Epidemiology Biomarkers & Prevention.

[2]  S. Meijer,et al.  The Perioperative Period is an Underutilized Window of Therapeutic Opportunity in Patients With Colorectal Cancer , 2009, Annals of surgery.

[3]  Carmen L. Lewis,et al.  Using quality improvement techniques to increase colon cancer screening. , 2009, The American journal of medicine.

[4]  J. Gu,et al.  Immunoglobulin expression in non-lymphoid lineage and neoplastic cells. , 2009, The American journal of pathology.

[5]  K. Umezawa,et al.  Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. , 2009, Current pharmaceutical design.

[6]  C. Reynolds,et al.  Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy , 2009, Clinical Cancer Research.

[7]  I. Fabregat.  Dysregulation of apoptosis in hepatocellular carcinoma cells. , 2009, World journal of gastroenterology.

[8]  L. Lili,et al.  The polymorphisms on Igkappa gene are related to susceptibility of breast cancer and gastric cancer. , 2008, Genetic testing.

[9]  J. Foster,et al.  Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. , 2008, The Journal of allergy and clinical immunology.

[10]  G. Morgan,et al.  Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. , 2007, Blood.

[11]  Ping-Chang Yang,et al.  TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. , 2007, Gastroenterology.

[12]  J. Gu,et al.  Immunoglobulin G expression in carcinomas and cancer cell lines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  B. Bonavida,et al.  ‘Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions’ , 2007, Oncogene.

[14]  Qi Dong,et al.  Expression of SNC73, a transcript of the immunoglobulin α-1 gene, in human epithelial carcinomas , 2007 .

[15]  Ya Cao,et al.  Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways. , 2007, Cellular signalling.

[16]  K. Shigeno,et al.  Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy , 2006, Clinical Cancer Research.

[17]  John Calvin Reed,et al.  Apoptosis-based therapies for hematologic malignancies. , 2005, Blood.

[18]  James R. Goldenring,et al.  Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.

[19]  Ya Cao,et al.  Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. , 2004, The international journal of biochemistry & cell biology.

[20]  J. Myers,et al.  Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases. , 2004, American journal of clinical pathology.

[21]  A. Fernandez-Flores,et al.  Involvement of the liver by multiple myeloma as nodular lesions: A case diagnosed by fine‐needle aspiration and immunocytochemistry , 2003, Diagnostic cytopathology.

[22]  Jian-bin Hu,et al.  Expression of a novel immunoglobulin gene SNC73 in human cancer and non-cancerous tissues. , 2003, World journal of gastroenterology.

[23]  Shaobo Yang,et al.  [Co-expression of immunoglobulin light chain kappa and lambda in gastric carcinoma cell]. , 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[24]  Qi Dong,et al.  Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas. , 2007, World journal of gastroenterology.

[25]  吉野 干城.  Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy , 2007 .

[26]  R. Poljak,et al.  Three-dimensional structure of immunoglobulins. , 1979, Annual review of biochemistry.